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Correlations between expression of interleukin (IL)-9, the calcium-activated chloride channel hCLCA1 and mucus expression in cystic fibrosis
(CF) airways have suggested a causal relationship. To verify this hypothesis mucosal tissue from upper airways of CF patients (N=5) was
stimulated with the Th2 type cytokines IL-4, IL-9, or IL-13. Expression of hCLCA1 mRNA and protein as well as mucus and mucin (MUC5AC)
gene expression was quantified using real time PCR, immunohistochemistry (hCLCA1) and PAS staining (mucus). Th2 type cytokines
significantly increased hCLCA1 protein expression (Pb0.05) whereas increase in hCLCA1 mRNA expression failed to reach statistical
significance (PN0.05). Mucin protein and MUC5AC mRNA expression were not significantly changed (PN0.05). These data suggest that Th2
type cytokines may increase hCLCA1 expression in CF but may not have a significant effect on mucus expression. Therefore the role of hCLCA1
as a mediator of mucus overexpression in CF has to be questioned.
© 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Airway; Cystic fibrosis; hCLCA1; Mucosa; Mucus; Th2 type cytokineIncreased mucus production (mucus hypersecretion) is a
hallmark of cystic fibrosis (CF) lung disease [1]. Excessive
amounts of mucus lead to airway obstruction and support
bacterial infection and colonization leading to inflammation and
loss of lung parenchyma. Previous studies have described
several mediators that induce mucin gene expression and mucus
protein production. These mediators include neutrophil elastase
(NE) and bacteria such as Pseudomonas aeruginosa (PA) as
well as bacterial products [2,3].
In addition, Th2 type cytokines have recently been im-
plicated in mucus induction in CF [4]. Previous studies have
indicated that a Th2 predominated immune response in CF may
favour PA colonization and infection [5,6]. A strong Th2 type
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doi:10.1016/j.jcf.2010.05.002aspergillosis (ABPA) that is frequently observed in CF patients.
We and others have shown Th2 type cytokine expression in the
airways and blood cells of CF patients [4,7,8]. The Th2 type
cytokines interleukin (IL)-4, IL-9, and IL-13 important
mediators of mucus expression in bronchial asthma [9–11].
Atherton and colleagues demonstrated increased MUC5AC
mRNA expression via a direct effect of IL-13 in epithelial cells
[12]. Th2-induced mucus expression is at least in part mediated
via the so-called calcium-activated chloride channel hCLCA1.
In CF airways the IL-9 receptor has been co-localised with
mucus expressing cells. Moreover, positive correlations be-
tween IL-9, mucus and the calcium activated chloride channel
hCLCA1 have been reported [4]. However, no functional
studies have been conducted so far to find out whether Th2 type
cytokine stimulation can really increase hCLCA1 and mucus
expression in CF airways.
Therefore we used explanted mucosal tissue from the upper
airways of five CF patients who underwent sinus surgery
(3 male, 2 female). As described previously mucin proteind by Elsevier B.V. All rights reserved.
Fig. 1. Change in hCLCA1 and mucin protein expression after stimulation with
Th2 type cytokines. Bars represent mean values+SEM. *: Pb0.05 vs control.
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Tissue was cultivated as previously described (37 °C, 5% CO2)
[14] for 24 hours without and with stimulation of recombinant
human (rh)IL-4, rhIL-9 or rhIL-13 at a concentration of 50 ng/ml.
Immunohistochemistry using a standard APAAP technique was
applied to differentiate and count inflammatory cells (CD68:
monocytes/macrophages; CD: lymphocytes; NE: neutrophils;
major basic protein, MBP: eosinophils) and hCLCA1 (anti-
hCLCA1 antibody; provided by Genaera Corp.) positive epithelial
cells. Periodic acid Schiff (PAS) staining was used to quantify
mucus protein expression although this method is not specific for
mucin proteins since it stains for glycoproteins. Gene expression of
hCLCA1 andMUC5AC (an important secretorymucin in airways)
in airway mucosa was measured using real time PCR (aminolae-
vulinat synthetase, ALAS-1 served as housekeeping gene). Primer
sequences were as follows: ALAS-1 5’-CCC ATG AGT TTG
GAG CAA TC –3’ and 5’-ACC CTC CAA CAC AAC CAA
AG -3’, MUC5AC 5’-TGA CCC ACC AGT GTG AGA AG –3’
and 5’-GGA TGA TCAGGC TCC TAT CG -3’, and hCLCA1
5’-GCA AGG TGG CTT TGT AGT GG -3’ and 5’-GGA ATT
TGC TGG TGT CCT TG -3’. Inflammatory cells were counted
per high powered field. Mucus and hCLCA1 expressing epithelial
cells were quantified as percentage of total epithelial cells. The
difference in the number of inflammatory cells and cells expressing
hCLCA1 as well as staining for mucus (PAS), were compared with
the nonparametric Kruskal-Wallis test. Statistically significant
differences between groups were subsequently analyzed with the
Wilcoxon matched pair test (Systat version 7.0; SPSS, Chicago,
Ill). Results are expressed as means±SEM and are significant at a
P value of less than 0.05.
Stimulation with Th2 type cytokines did not significantly
change inflammatory cells counts (Table 1). RhIL-4, rhIL-9,
and rhIL-13 increased mucus expression compared to unstimu-
lated tissue (28.1±9.1% vs 37.5±8.8%, 33.3±10.2%, and 45.8±
13.5%, respectively). However, this effect was not statistically
significant (PN0.05). In contrast, all Th2 type cytokines
significantly increased epithelial hCLCA1 protein expression
(53.1±12.3% vs 66.7±13.5%, 79.2±18.4%, and 91.7±10.2%,
respectively) (Pb0.05) (Fig. 1). A small but not significant change
in hCLCA1 mRNA expression was observed with Th2 type
cytokine stimulation (PN0.05) (Fig. 2). There was also no increase
in MUC5AC gene expression following stimulation with Th2 type
cytokines (data not shown).
Our experiments show that Th2 type cytokines can induce
hCLCA1 mRNA and protein expression in CF airway mucosa
whereas mucus expression was not significantly affected. Previous
reports have demonstrated a strong correlation between IL-9, itsTable 1
Inflammatory cell counts.
Control +rhIL-4 +rhIL-9 +rhIL-13
CD68+ve cells 20.1±2.1 24.3±6.4 19.0±1.3 13.2±4.2
CD3+ve cells 25.5±9.9 38.0±14.6 44.5±18.9 40.2±16.5
NE+ve cells 23.4±8.2 26.8±15.2 34.0±18.0 18.7±4.9
MBP+ve cells 2.7±2.8 1.2±1.2 1.1±0.1 3.7±1.3
CD68: monocytes/macrophages. CD3: lymphocytes. NE: neutrophils. MBP:
eosinophils. Mean values±SEM.receptor, hCLCA1 and mucus expression in upper and lower
airways of CF patients [4]. However, those studies did not provide
functional data showing a clear induction of hCLCA1 and mucus
after IL-9 stimulation. In the present studywe found that IL-4, IL-9,
and IL-13 increased hCLCA1 expression in CF mucosa. This
finding agrees with data from the literature on non-CF airway
mucosa [15].
Interestingly we did not observe any significant changes in
MUC5AC gene and mucus expression. It is possible that other
mucin genes such as MUC5B or MUC2 may behave differently
but this would not explain that mucus protein expression did
not significantly change. It may be due to the short time frame
of 24 hours. Longer stimulation may lead to increased mucus
expression. In fact, Th2 type cytokines can be regarded as
milieu modifiers meaning that long-term stimulation eventually
leads to goblet cell metaplasia. On the other hand data from the
literature have shown increased mucin gene expression in cell
culture after 24 hours of stimulation [9,10]. Another possible
explanation is that the effect of Th2 type cytokines is attenuated
by the plethora of other mucus secretagogues in CF airway
mucosa (e.g. neutrophil elastase) [2,3].
Despite being primarily described as a chloride channel it has
now become clear that hCLCA1 facilitates chloride currents
but it is not an ion channel itself [16]. Moreover, hCLCA1 may
play an important role during exocytosis of mucin proteins.
Although its exact role remains to be further studied several
studies have shown that inhibition of hCLCA1 leads to decreased
mucus expression in both allergic and non-allergic disease [17,18].
Based on the findings in the present study the role of hCLCA1 in
CF-associated mucus hypersecretion has to be questioned since we
did not observe a significant change in mucus expression after
stimulation with IL-4, IL-9 or IL-13 but a significant increase in
hCLCA1 expression. It is possible that Th2 type cytokines andFig. 2. Change in hCLCA1 mRNA expression after stimulation with Th2 type
cytokines. Bars represent mean values+SEM.
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ABPA. This has to be further evaluated.
Although mucus hypersecretion in CF has to be considered
to be mainly due to neutrophilic inflammation and release of
NE Th2 type cytokines may also play an important role in certain
conditions (eg. ABPA). Thus, blocking Th2 type cytokines or
more specific hCLCA1 (e.g. with niflumic acid)may be beneficial
in selected patients.
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